Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a commercial biopharmaceutical company dedicated to manufa
ADMA Biologics Announces Data Presented at IDWeek 2019
07:08am, Monday, 07'th Oct 2019
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 07, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and s
ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference
07:08am, Monday, 23'rd Sep 2019
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 23, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and
ADMA: Ready To Capitalize On The IVIG Shortage
11:09pm, Tuesday, 03'rd Sep 2019
ADMA Biologics has re-launched their IVIG product, BIVIGAM, during a nationwide IG shortage. With ASCENIV's launch approaching, I expect ADMA to capitalize on the current market conditions.
ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
07:48am, Thursday, 22'nd Aug 2019
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and s
ADMA Biologics: Selloff Creates Buying Opportunity
04:35pm, Tuesday, 18'th Jun 2019
For a company that just racked up two significant regulatory wins, ADMA Biologics Inc.
7 High-Quality Cheap Stocks to Buy With $10
12:27pm, Wednesday, 12'th Jun 2019
These seven cheap stocks under $10 all have massive upside potential according to Wall Street's top analysts.
The post 7 High-Quality Cheap Stocks to Buy With $10 appeared first on InvestorPlace.
ADMA Biologics Is De-Risked and Ready to Rise
06:14pm, Thursday, 30'th May 2019
After years of struggle, ADMA Biologics appears at last to be poised for bigger things.
ADMA Biologics: Significant Derisking, Product Launches In Second Half Of The Year
04:05pm, Tuesday, 28'th May 2019
Shares have lost over a third of their value during the past three years.
ADMA Biologics: Under-The-Radar Biotech With Huge Potential Upside
12:33am, Wednesday, 22'nd May 2019
Since April, ADMA has won approval for two IVIG products, Asceniv and Bivigam, as well as approval to manufacture them in its vertically integrated facility.
The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings
08:19am, Wednesday, 03'rd Apr 2019
Here's a roundup of top developments in the biotech space over the last 24 hours.
ADMA Biologics Rips Higher On FDA Nod For Immunodeficiency Therapy
10:26am, Tuesday, 02'nd Apr 2019
Microcap specialty pharma company ADMA Biologics Inc. advanced in the last two trading days in anticipation of a binary event, and with the event materializing in favor of the company, the stock has t
ADMA Biologics' stock rockets on heavy volume after FDA approval of immunodeficiency treatment
09:00am, Tuesday, 02'nd Apr 2019
Shares of ADMA Biologics Inc. rocketed 54% in very active premarket trade Tuesday.
ADMA Biologics Investors Prepare For RI-002 PDUFA
09:09am, Monday, 01'st Apr 2019
Back on December 19th, ADMA Biologics (ADMA) received a complete response letter "CRL" from the FDA concerning their PAS for BIVIGAM.
